Acadia Pharmaceuticals
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 17 annual filings
Revenue
$1.07B
Net Income
$391.00M
Assets
$1.56B
EPS (diluted)
$2.30
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-072519Acadia Pharmaceuticals
Summary
Acadia Pharmaceuticals is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (289 views/month).[2]
Key Facts
- Acadia Pharmaceuticals is in the country of United States[3].
- Acadia Pharmaceuticals is in the country of US[4].
- Acadia Pharmaceuticals's instance of is recorded as business[5].
- Acadia Pharmaceuticals's instance of is recorded as public company[6].
- Acadia Pharmaceuticals's headquarters location is recorded as San Diego[7].
- Acadia Pharmaceuticals's stock exchange is recorded as Nasdaq[8].
- Acadia Pharmaceuticals's industry is recorded as pharmaceutical industry[9].
- 1993 marks the founding of Acadia Pharmaceuticals[10].
- Acadia Pharmaceuticals's official website is recorded as http://www.acadia-pharm.com/[11].
- Acadia Pharmaceuticals's product or material produced is recorded as pimavanserin[12].
- Acadia Pharmaceuticals's legal form is recorded as 8888[13].
Body
Founding
1993 marks the founding of Acadia Pharmaceuticals[10].
Operations
Acadia Pharmaceuticals's headquarters location is recorded as San Diego[7].
Industry
Acadia Pharmaceuticals's industry is recorded as pharmaceutical industry[9].
Ownership
Acadia Pharmaceuticals's stock exchange is recorded as Nasdaq[8]. Its product or material produced is recorded as pimavanserin[12].
Why It Matters
Acadia Pharmaceuticals ranks in the top 4% of business entities by monthly Wikipedia readership (289 views/month).[2]